Multidrug resistance characterization in multicellular tumour spheroids from two human lung cancer cell lines

被引:37
作者
Barrera-Rodriguez, Raul [1 ]
Morales Fuentes, Jorge [2 ]
机构
[1] Inst Nacl Enfermedades Resp, Dept Bioquim & Med Ambiental, 4502 Col Sec 16, Mexico City 14080, DF, Mexico
[2] Hosp Cent Sur, Serv Neumol, Mexico City, DF, Mexico
关键词
Multicellular tumour cancer spheroids; Multicellular resistance; Multidrug resistance genes; Drug cytotoxicity; Three-dimensional culture; Lung cancer; HAMSTER V79 MONOLAYERS; TOPOISOMERASE-II; DRUG-RESISTANCE; P-GLYCOPROTEIN; CHEMOTHERAPY; PENETRATION; EXPRESSION; GROWTH; ETOPOSIDE; ENVIRONMENT;
D O I
10.1186/s12935-015-0200-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Background: Most of the knowledge about the mechanisms of multidrug resistance in lung cancer has been achieved through the use of cell lines isolated from tumours cultivated either in suspensions of isolated cells or in monolayers and following exposition to different cytostatic agents. However, tumour cell lines growing as multicellular tumour spheroids (MTS) frequently develop multicellular resistance in a drug-independent form. The aim of this study was to characterize the phenotypic and functional differences between two human NSCLC cell lines (INER-37 and INER-51) grown as traditional monolayer cultures versus as MTS. Methods: After 72 hours treatment with anticancer drugs, chemosensitivity in monolayers and tumour spheroids cultures was assessed using MTT assay. Reverse transcription-polymerase chain reaction was employed to detect the mRNAs of multidrug resistance-related genes. The expression of P-gp was analyzed by immunohistochemical staining and cell cycle profiles were analyzed using FACS. Results: The results indicate that when grown as MTS each lung cancer cell line had different morphologies as well as and abrogation of cell proliferation with decrease of the G(2)/M phase. Also, MTS acquired multicellular resistance to several chemotherapeutic agents in only a few days of culture which were accomplished by significant changes in the expression of MDR-related genes. Conclusion: Overall, the MTS culture changed the cellular response to drugs nevertheless each of the cell lines studied seems to implement different mechanisms to acquire multicellular resistance.
引用
收藏
页数:11
相关论文
共 46 条
[1]
[Anonymous], 2013, GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC cancer base
[2]
Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data [J].
Auperin, A. ;
Le Chevalier, T. ;
Le Pechoux, C. ;
Pignon, J. P. ;
Tribodet, H. ;
Burdett, S. ;
Stewart, L. A. ;
Tierney, J. F. ;
Stephens, R. J. ;
Arriagada, R. ;
Higgins, J. P. ;
Johnson, D. H. ;
van Meerbeeck, J. ;
Parmar, M. K. B. ;
Souhami, R. L. ;
Bergman, B. ;
Dautzenberg, B. ;
Douillard, J. Y. ;
Dunant, A. ;
Endo, C. ;
Girling, D. J. ;
Imaizumi, M. ;
Kato, H. ;
Keller, S. M. ;
Kimura, H. ;
Knuuttila, A. ;
Kodama, K. ;
Komaki, R. ;
Kris, M. G. ;
Lad, T. ;
Mineo, T. ;
Park, J. H. ;
Piantadosi, S. ;
Pyrhonen, S. ;
Rosell, R. ;
Scagliotti, G. V. ;
Seymour, L. W. ;
Shepherd, F. A. ;
Spiro, S. G. ;
Strauss, G. M. ;
Sylvester, R. ;
Tada, H. ;
Tanaka, F. ;
Torri, V. ;
Wada, H. ;
Waller, D. ;
Xu, G. C. .
LANCET, 2010, 375 (9722) :1267-1277
[3]
A family of drug transporters: The multidrug resistance-associated proteins [J].
Borst, P ;
Evers, R ;
Kool, M ;
Wijnholds, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (16) :1295-1302
[4]
GENETIC MECHANISMS OF DRUG-RESISTANCE - A REVIEW [J].
BORST, P .
ACTA ONCOLOGICA, 1991, 30 (01) :87-105
[5]
Breen L, 2011, METHODS MOL BIOL, V731, P125, DOI 10.1007/978-1-61779-080-5_11
[6]
RELATIONS BETWEEN PH, OXYGEN PARTIAL-PRESSURE AND GROWTH IN CULTURED-CELL SPHEROIDS [J].
CARLSSON, J ;
ACKER, H .
INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (05) :715-720
[7]
Cell adhesion and signalling by cadherins and Ig-CAMs in cancer [J].
Cavallaro, U ;
Christofori, G .
NATURE REVIEWS CANCER, 2004, 4 (02) :118-132
[8]
DNA Topoisomerase II Enzymes as Molecular Targets for Cancer Chemotherapy [J].
Chikamori, K. ;
Grozav, A. G. ;
Kozuki, T. ;
Grabowski, D. ;
Ganapathi, R. ;
Ganapathi, M. K. .
CURRENT CANCER DRUG TARGETS, 2010, 10 (07) :758-771
[9]
Transport of glutathione and glutathione conjugates by MRP1 [J].
Cole, Susan P. C. ;
Deeley, Roger G. .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2006, 27 (08) :438-446
[10]
Targeting Multidrug Resistance Protein 1 (MRP1, ABCC1): Past, Present, and Future [J].
Cole, Susan P. C. .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54, 2014, 54 :95-+